TRAF6 and lung carcinoma: TNF receptor‐associated factor 6 (TRAF6) promotes the development of human lung cancer through bridging RAS and NF‐kB pathways; on the other hand, thioredoxin‐interacting protein (TXNIP) suppresses the growth of tumors.